Cargando…

Patient-reported Outcomes and Burden of Disease in Paediatric Patients with Psoriasis: Real-world Data from EU5 and US

Detalles Bibliográficos
Autores principales:	SEYGER, Marieke M. B., PALLER, Amy S., STICHERLING, Michael, BACHHUBER, Teresa, THOMAS, Nicolas, HETHERINGTON, James, LUCAS, James, RICHARDSON, Craig, AUGUSTIN, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128148/ https://www.ncbi.nlm.nih.gov/pubmed/37073960 http://dx.doi.org/10.2340/actadv.v103.2544

Ejemplares similares

Physician-reported Clinical Unmet Needs, Burden and Treatment Patterns of Paediatric Psoriasis Patients: A US and EU Real-world Evidence Study
por: SEYGER, Marieke M. B., et al.
Publicado: (2022)

Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate‐to‐severe psoriasis: a post hoc analysis from IXORA‐PEDS
por: Seyger, M.M.B., et al.
Publicado: (2021)

Population pharmacokinetic and exposure–efficacy analysis of ixekizumab in paediatric patients with moderate‐to‐severe plaque psoriasis (IXORA‐PEDS)
por: Jackson, Kimberley, et al.
Publicado: (2021)

Real-world Methotrexate Use in a Prospective Cohort of Paediatric Patients with Plaque Psoriasis: Effectiveness, Adverse Events and Folic Acid Regimen
por: BRUINS, Finola M., et al.
Publicado: (2022)

Patient Characteristics and Treatment Patterns in European Pediatric Patients with Psoriasis: A Real-World, Cross-Sectional Study
por: Sticherling, Michael, et al.
Publicado: (2022)

Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US
por: Ingram, J.R., et al.
Publicado: (2022)

Efficacy and safety of ixekizumab in a phase III, randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis (IXORA‐PEDS)
por: Paller, A.S., et al.
Publicado: (2020)

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial
por: Paller, Amy S., et al.
Publicado: (2022)

Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities
por: Bronckers, I. M. G. J., et al.
Publicado: (2015)

Safety of ustekinumab in adolescent patients with moderate‐to‐severe plaque psoriasis: real‐world evidence from an ongoing European study (NCT03218488)
por: Mahé, E., et al.
Publicado: (2022)

Adalimumab for severe psoriasis in Chilean paediatric patients()()
por: Armijo Fernandez, Daniela, et al.
Publicado: (2020)

Miliary tuberculosis in a paediatric patient with psoriasis
por: Kilgore, Jacob, et al.
Publicado: (2021)

Treatment persistence in paediatric and adolescent patients with psoriasis followed into young adulthood. From topical to systemic treatment: a prospective, longitudinal, observational cohort study of 448 patients
por: Bruins, F.M., et al.
Publicado: (2020)

The Effect of Lifestyle Changes on Disease Severity and Quality of Life in Patients with Plaque Psoriasis: A Narrative Review
por: van Acht, Maartje R, et al.
Publicado: (2022)

Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis
por: Luna, Paula C., et al.
Publicado: (2023)

Handheld versus mounted laser speckle contrast perfusion imaging demonstrated in psoriasis lesions
por: Chizari, Ata, et al.
Publicado: (2021)

Real-world burden of comorbidities in US patients with psoriatic arthritis
por: Shah, Kamal, et al.
Publicado: (2017)

Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study
por: Thaçi, D., et al.
Publicado: (2019)

Disease Burden and Treatment Patterns of Psoriasis in Russia: A Real-World Patient and Dermatologist Survey
por: Kubanov, Alexey A., et al.
Publicado: (2018)

Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database
por: Feldman, Steven R., et al.
Publicado: (2017)

Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective
por: Auby, Philippe
Publicado: (2008)

Psoriasis Causes Significant Economic Burden to Patients
por: Mustonen, A., et al.
Publicado: (2014)

The burden of psoriasis in patients with early psoriatic arthritis
por: Kasiem, Fazira R, et al.
Publicado: (2021)

Economic Burden of Comorbidities in Patients with Psoriasis in the USA
por: Wu, Jashin J., et al.
Publicado: (2022)

Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey
por: Armstrong, April W., et al.
Publicado: (2023)

Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan(®) Databases
por: Leonardi, Craig, et al.
Publicado: (2022)

 Regulatory Considerations for Gene Therapy Products in the US, EU, and Japan 
por: Halioua-Haubold, Celine-Lea, et al.
Publicado: (2017)

Gender differences in health of EU10 and EU15 populations: the double burden of EU10 men
por: Nusselder, W. J., et al.
Publicado: (2010)

EU GDPR & EU-US Privacy Shield: A Pocket Guide
por: Calder, Alan
Publicado: (2017)

EU GDPR & EU-U.S. Privacy Shield: A pocket guide
por: Calder, Alan
Publicado: (2019)

Documenting Patient Data in Psoriasis Clinical Practice—Patient Focus Groups Supporting Psoriasis Experts’ Decision-making
por: Otten, Marina, et al.
Publicado: (2021)

Behandlung der Psoriasis mit Secukinumab: Praxisrelevante Hinweise
por: Körber, Andreas, et al.
Publicado: (2021)

Patient–physician (dis)agreement on their reports of body surface area affected by psoriasis and its associations with disease burden
por: da Silva, N., et al.
Publicado: (2022)

Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis
por: ACHTEN, Roselie, et al.
Publicado: (2023)

The WorldGrid transatlantic testbed: a successful example of Grid interoperability across EU and U.S. domains
por: Donno, Flavia, et al.
Publicado: (2003)

PReS13-SPK-1182: Six years of eu paediatric regulation - what was achieved for paediatric rheumatology
por: Vesely, R
Publicado: (2013)

Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population
por: Lee, Seina, et al.
Publicado: (2018)

Perfusion measured by laser speckle contrast imaging as a predictor for expansion of psoriasis lesions
por: Schaap, Mirjam J., et al.
Publicado: (2021)

Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry
por: Strober, Bruce, et al.
Publicado: (2019)

ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients
por: Schwarz, Peter E. H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ijd5hhdnlp700d6j2e3s55js8j